Worldwide coronavirus cases surpassed 90 million on Jan. 11, according to a Reuters tally, as nations around the globe scramble to procure vaccines and continue to extend or reinstate lockdowns to fight new coronavirus variants.
Japan’s Covid-19 cases reached a new daily record on Jan. 6, as the government faced mounting pressure from health experts to impose a strict state of emergency for the Tokyo greater metropolitan area.
“If we’ve learned anything this year, it’s that kindness is also contagious.” This is the rallying cry behind Klick Health’s 2020 holiday video ‘When Nobody’s Watching’, which launched on Dec. 8 on YouTube. For each view, Klick will donate $1 to Sesame Workshop, the non-profit media and education organization behind Sesame Street that’s known for its mission to help children grow smarter, stronger, and kinder.
California shattered records for coronavirus cases on Dec. 6 as U.S. states scrambled to impose lockdowns to stem spikes in infections and the White House’s task force coordinator decried a lack of national leadership on curbing the disease.
The mayor of San Francisco ordered new lockdowns and business restrictions across the Bay Area in the face of the Covid-19 surge, as political leaders nationwide ramp up pressure on Americans to stay home until vaccines can be distributed.
Nearly all social gatherings of individuals from more than a single household will be banned in Los Angeles County for at least three weeks starting Nov. 30 under new restrictions unveiled by local health officials, citing a continued surge in Covid-19 infections.
People who have had Covid-19 are highly unlikely to contract the disease again for at least six months after their first infection, according to a British study of healthcare workers on the frontline of the fight against the coronavirus pandemic.
Adult obesity is rising in the United States – with a greater impact on racial and ethnic minorities – a U.S. Centers for Disease Control (CDC) report showed, at a time when the health condition is seen causing heightened risk for severe Covid-19.
AstraZeneca Plc said the company’s asthma treatment Fasenra for a chronic inflammatory disease of the nasal passage linings, or sinuses, met main goals in a late-stage study.
Shelton, Connecticut-based NanoViricides outlined the company’s approach to developing therapies against Covid-19 at the LD 500 investor conference.